Literature DB >> 31175395

Physician centred imaging interpretation is dying out - why should I be a nuclear medicine physician?

Roland Hustinx1,2.   

Abstract

Radiomics, machine learning, and, more generally, artificial intelligence (AI) provide unique tools to improve the performances of nuclear medicine in all aspects. They may help rationalise the operational organisation of imaging departments, optimise resource allocations, and improve image quality while decreasing radiation exposure and maintaining qualitative accuracy. There is already convincing data that show AI detection, and interpretation algorithms can perform with equal or higher diagnostic accuracy in various specific indications than experts in the field. Preliminary data strongly suggest that AI will be able to process imaging data and information well beyond what is visible to the human eye, and it will be able to integrate features to provide signatures that may further drive personalised medicine. As exciting as these prospects are, they currently remain essentially projects with a long way to go before full validation and routine clinical implementation. AI uses a language that is totally unfamiliar to nuclear medicine physicians, who have not been trained to manage the highly complex concepts that rely primarily on mathematics, computer sciences, and engineering. Nuclear medicine physicians are mostly familiar with biology, pharmacology, and physics, yet, considering the disruptive nature of AI in medicine, we need to start acquiring the knowledge that will keep us in the position of being actors and not merely witnesses of the wonders developed by other stakeholders in front of our incredulous eyes. This will allow us to remain a useful and valid interface between the image, the data, and the patients and free us to pursue other, one might say nobler tasks, such as treating, caring and communicating with our patients or conducting research and development.

Entities:  

Keywords:  Artificial intelligence; Molecular imaging; Nuclear medicine; Radiomics

Mesh:

Year:  2019        PMID: 31175395     DOI: 10.1007/s00259-019-04371-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  47 in total

1.  Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study.

Authors:  Christiane K Kuhl; Yunus Alparslan; Jonas Schmoee; Bruno Sequeira; Annika Keulers; Tim H Brümmendorf; Sebastian Keil
Journal:  Radiology       Date:  2018-11-06       Impact factor: 11.105

Review 2.  Perceptual and Interpretive Error in Diagnostic Radiology-Causes and Potential Solutions.

Authors:  Andrew J Degnan; Emily H Ghobadi; Peter Hardy; Elizabeth Krupinski; Elena P Scali; Lindsay Stratchko; Adam Ulano; Eric Walker; Ashish P Wasnik; William F Auffermann
Journal:  Acad Radiol       Date:  2018-12-14       Impact factor: 3.173

Review 3.  Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.

Authors:  Zong Ruilong; Xie Daohai; Geng Li; Wang Xiaohong; Wang Chunjie; Tian Lei
Journal:  Nucl Med Commun       Date:  2017-01       Impact factor: 1.690

4.  3D conditional generative adversarial networks for high-quality PET image estimation at low dose.

Authors:  Yan Wang; Biting Yu; Lei Wang; Chen Zu; David S Lalush; Weili Lin; Xi Wu; Jiliu Zhou; Dinggang Shen; Luping Zhou
Journal:  Neuroimage       Date:  2018-03-20       Impact factor: 6.556

5.  Probability of cancer in pulmonary nodules detected on first screening CT.

Authors:  Annette McWilliams; Martin C Tammemagi; John R Mayo; Heidi Roberts; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; Simon Martel; Francis Laberge; Michel Gingras; Sukhinder Atkar-Khattra; Christine D Berg; Ken Evans; Richard Finley; John Yee; John English; Paola Nasute; John Goffin; Serge Puksa; Lori Stewart; Scott Tsai; Michael R Johnston; Daria Manos; Garth Nicholas; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Alain Tremblay; Paul Burrowes; Paul MacEachern; Rick Bhatia; Ming-Sound Tsao; Stephen Lam
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 6.  Diagnostic Accuracy of Myocardial Perfusion Imaging With CZT Technology: Systemic Review and Meta-Analysis of Comparison With Invasive Coronary Angiography.

Authors:  Francesco Nudi; Ami E Iskandrian; Orazio Schillaci; Mariangela Peruzzi; Giacomo Frati; Giuseppe Biondi-Zoccai
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

7.  Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.

Authors:  Moritz Schwyzer; Daniela A Ferraro; Urs J Muehlematter; Alessandra Curioni-Fontecedro; Martin W Huellner; Gustav K von Schulthess; Philipp A Kaufmann; Irene A Burger; Michael Messerli
Journal:  Lung Cancer       Date:  2018-11-03       Impact factor: 5.705

8.  Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.

Authors:  Paul Cronin; Ben A Dwamena; Aine Marie Kelly; Ruth C Carlos
Journal:  Radiology       Date:  2008-01-30       Impact factor: 11.105

9.  Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.

Authors:  Takayuki Shibutani; Kenichi Nakajima; Hiroshi Wakabayashi; Hiroshi Mori; Shinro Matsuo; Hiroto Yoneyama; Takahiro Konishi; Koichi Okuda; Masahisa Onoguchi; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2018-10-09       Impact factor: 2.668

10.  FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.

Authors:  Nils Helsen; Tim Van den Wyngaert; Laurens Carp; Sigrid Stroobants
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-24       Impact factor: 9.236

View more
  5 in total

1.  EJNMMI supplement: bringing AI and radiomics to nuclear medicine.

Authors:  Patrick Veit-Haibach; Irène Buvat; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12       Impact factor: 9.236

Review 2.  A review of the application of machine learning in molecular imaging.

Authors:  Lin Yin; Zhen Cao; Kun Wang; Jie Tian; Xing Yang; Jianhua Zhang
Journal:  Ann Transl Med       Date:  2021-05

Review 3.  Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.

Authors:  Manja Kubeil; Irma Ivette Santana Martínez; Michael Bachmann; Klaus Kopka; Kellie L Tuck; Holger Stephan
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

Review 4.  Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology.

Authors:  Martina Sollini; Francesco Bartoli; Andrea Marciano; Roberta Zanca; Riemer H J A Slart; Paola A Erba
Journal:  Eur J Hybrid Imaging       Date:  2020-12-09

Review 5.  Applications of artificial intelligence and deep learning in molecular imaging and radiotherapy.

Authors:  Hossein Arabi; Habib Zaidi
Journal:  Eur J Hybrid Imaging       Date:  2020-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.